{"id":"https://openalex.org/W2582857650","doi":"https://doi.org/10.1182/blood.v120.21.1643.1643","title":"A Phase I Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), in Combination with Rituximab (R) and Bendamustine in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL)","display_name":"A Phase I Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), in Combination with Rituximab (R) and Bendamustine in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL)","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2582857650","doi":"https://doi.org/10.1182/blood.v120.21.1643.1643","mag":"2582857650"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.1643.1643","doi":"https://doi.org/10.1182/blood.v120.21.1643.1643","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.1643.1643","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056946123","display_name":"Kristie A. Blum","orcid":"https://orcid.org/0000-0001-7363-9794","observed_orcids":["https://orcid.org/0000-0001-7363-9794","https://orcid.org/0000-0003-4229-2569"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristie A. Blum","raw_affiliation_strings":["Internal Medicine, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104068814","display_name":"Beth A. Christian","orcid":"https://orcid.org/0009-0008-6077-3669","observed_orcids":["https://orcid.org/0009-0008-6077-3669"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth Christian","raw_affiliation_strings":["Hematology, The Ohio State University-James Cancer Center, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, The Ohio State University-James Cancer Center, Columbus, OH, USA,","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019749214","display_name":"Joseph M. Flynn","orcid":"https://orcid.org/0000-0003-1767-9235","observed_orcids":["https://orcid.org/0000-0003-1767-9235"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Flynn","raw_affiliation_strings":["Hematology, The Ohio State University-James Cancer Center, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, The Ohio State University-James Cancer Center, Columbus, OH, USA,","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072835425","display_name":"Samantha Mary Jaglowski","orcid":"https://orcid.org/0000-0002-4335-2554","observed_orcids":["https://orcid.org/0000-0002-4335-2554"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha M. Jaglowski","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102896676","display_name":"Jeffrey Alan Jones","orcid":"https://orcid.org/0000-0001-9557-0820","observed_orcids":["https://orcid.org/0000-0001-9557-0820"]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Alan Jones","raw_affiliation_strings":["Division of Hematology, Ohio State University Medical Center, Columbus, OH, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Ohio State University Medical Center, Columbus, OH, USA,","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024389256","display_name":"Kami J. Maddocks","orcid":"https://orcid.org/0000-0001-8519-8404","observed_orcids":["https://orcid.org/0000-0001-8519-8404"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kami Maddocks","raw_affiliation_strings":["Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000921376","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0001-9830-0711","observed_orcids":["https://orcid.org/0000-0001-9830-0711"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":["Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5024389256"],"corresponding_institution_ids":["https://openalex.org/I52357470"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":3.0327,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.91831127,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"120","issue":"21","first_page":"1643","last_page":"1643"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.5019999742507935,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.5019999742507935,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.4968000054359436,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9649999737739563},{"id":"https://openalex.org/keywords/bendamustine","display_name":"bendamustine","score":1.0},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.7080000042915344},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.746999979019165},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9660000205039978},{"id":"https://openalex.org/keywords/marginal-zone-lymphoma","display_name":"marginal zone lymphoma","score":0.8029999732971191},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9380000233650208},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9430000185966492},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5320000052452087},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.9214881658554077},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.8989523649215698},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6630193591117859},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.6315634250640869},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5933446884155273},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5896125435829163},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.5686280131340027},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.44244688749313354},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4188990890979767},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35076314210891724},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33897000551223755},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.33270263671875},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2152479588985443},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.20856401324272156},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.17702937126159668},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.12365663051605225},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.1643.1643","doi":"https://doi.org/10.1182/blood.v120.21.1643.1643","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.1643.1643","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1974084203","https://openalex.org/W167055487","https://openalex.org/W2553910750","https://openalex.org/W2588919636","https://openalex.org/W2586313031","https://openalex.org/W2949600157","https://openalex.org/W2891566720","https://openalex.org/W4404578508","https://openalex.org/W2890217044","https://openalex.org/W7099352191"],"abstract_inverted_index":{"Abstract":[0,1],"1643":[2],"Introduction:":[3],"Ibrutinib":[4,650],"is":[5,98,651],"an":[6],"orally":[7],"available,":[8],"irreversible":[9],"inhibitor":[10],"of":[11,133,195,210,284,293,386,395,401,424,657],"BTK,":[12],"a":[13,28,70,99,281,291],"downstream":[14],"protein":[15],"in":[16,32,51,76,108,135,139,333,337,342,348,351,356,531,548,558,585,606,633],"the":[17,41,121,442,586,621,655],"B-cell":[18,25,36,60],"receptor":[19],"signaling":[20],"pathway":[21],"critical":[22],"for":[23,165,222,251,414,453,534,551,654],"normal":[24],"development.":[26],"In":[27,69],"phase":[29,71,114],"I":[30,115],"study":[31,75,116,183,440],"patients":[33,52,87,109,140,147,158,226,234,252,277,302,311,316,323,380,405,430,438,444,461,533,564,588,607,616,634],"with":[34,48,53,84,103,110,137,141,148,159,253,280,290,392,445,462,474,480,562,589,594,603,608,635],"relapsed":[35,54,612],"malignancies":[37],"(Fowler":[38],"ASH":[39,79],"2010),":[40],"overall":[42],"response":[43,584],"rate":[44],"(ORR)":[45],"was":[46,82,117,249,261,556],"43%,":[47],"responses":[49,580],"observed":[50],"mantle":[55],"cell":[56,168],"(MCL),":[57],"diffuse":[58],"large":[59],"(DLBCL),":[61],"follicular":[62],"(FL),":[63],"and":[64,96,130,155,157,175,189,205,207,266,321,353,398,421,447,464,469,471,517,539,581,602,611,626,638],"marginal":[65],"zone":[66],"lymphoma":[67],"(MZL).":[68],"II":[72],"single":[73],"agent":[74],"MCL":[77,162,360,475,639],"(Wang":[78],"2011),":[80],"ORR":[81,104,555],"67%":[83],"several":[85],"responding":[86],"remaining":[88],"on":[89],"ibrutinib":[90,138,190,211,237,396,402,479,525,593],"over":[91],"1":[92,204,413,472,549,582],"year.":[93],"Rituximab":[94],"(R)":[95],"bendamustine":[97,201],"highly":[100],"active":[101],"regimen":[102],"ranging":[105],"from":[106,522],"52\u201392%":[107],"relapsed/refractory":[111,142,149],"NHL.":[112,143,658],"This":[113],"designed":[118],"to":[119,305,410,432,456,485,526,544,620],"determine":[120],"maximum":[122],"tolerated":[123,598],"dose,":[124],"dose":[125,231,542,624],"limiting":[126],"toxicity":[127,601],"(DLT),":[128],"toxicities,":[129],"preliminary":[131,604],"efficacy":[132],"R-bendamustine":[134,481,595],"combination":[136,631],"Methods:":[144],"Eligibility":[145],"included":[146,329,359,441,504,577],"FL,":[150,636],"MZL,":[151],"MCL,":[152],"transformed":[153,372,448],"NHL,":[154],"DLBCL,":[156,637],"previously":[160,288,609],"untreated":[161,610],"not":[163,571,652],"candidates":[164],"autologous":[166],"stem":[167],"transplantation":[169],"(ASCT).":[170],"ANC":[171],"\u22651000/mm3,":[172],"platelets":[173],"\u226550,000/mm3,":[174],"creatinine":[176],"\u2264":[177],"2.0":[178],"mg/dL":[179],"were":[180,191,227,299,303,427,451,529],"required":[181,530,547],"at":[182,229,418],"entry.":[184],"Prior":[185],"ASCT,":[186,314],"rituximab,":[187],"bendamustine,":[188,320],"permitted.":[192],"Treatment":[193],"consisted":[194],"R":[196],"375":[197],"mg/m2":[198],"day":[199],"1,":[200,459],"90":[202],"mg/m2days":[203],"2,":[206],"escalating":[208],"doses":[209],"(280":[212],"mg":[213,394,400,420,423,478,524,528,623],"or":[214,245,383],"560":[215,399,422,622],"mg)":[216],"days":[217,221,492],"1\u201328":[218],"every":[219],"28":[220],"6":[223,241,267],"cycles.":[224],"Six":[225,301,429],"enrolled":[228],"each":[230],"level.":[232],"Responding":[233],"could":[235],"continue":[236,431],"alone":[238],"after":[239,263,466,493],"cycle":[240,412,458,494],"until":[242],"disease":[243,332,416],"progression":[244],"unacceptable":[246],"toxicity.":[247],"Pegfilgrastim":[248],"permitted":[250],"grade":[254,486,535,552],"4":[255,310],"neutropenia":[256,488,507],"during":[257],"cycles":[258,264,385,467],"1\u20136.":[259],"Response":[260],"assessed":[262],"3":[265,294,468,487,532,536,553,563,587],"by":[268,368],"International":[269],"Harmonization":[270],"Criteria":[271],"(Cheson,":[272],"JCO":[273],"2007).":[274],"Results:":[275],"Eleven":[276],"(9":[278],"males)":[279],"median":[282,292],"age":[283],"72":[285],"(range":[286,297],"45\u201384)":[287],"treated":[289],"prior":[295,313,319,325,409,455],"therapies":[296],"0\u201310)":[298],"enrolled.":[300],"refractory":[304],"their":[306],"most":[307],"recent":[308],"therapy,":[309],"had":[312,317,324],"2":[315,443,460,578],"received":[318],"no":[322],"ibrutinib.":[326],"Other":[327],"characteristics":[328],"stage":[330],"III-IV":[331],"82%,":[334],"extranodal":[335],"involvement":[336],"64%,":[338],"elevated":[339,354],"IPI":[340],"\u22653":[341],"55%,":[343],"bulky":[344],"adenopathy":[345],"\u22655":[346],"cm":[347],"45%,":[349,352],"B-symptoms":[350],"LDH":[355],"36%.":[357],"Histologies":[358],"(n=3),":[361],"DLBCL":[362,446,463],"(n=3,":[363],"all":[364],"germinal":[365],"center":[366],"origin":[367],"Hans":[369],"immunohistochemical":[370],"criteria),":[371],"NHL":[373,449],"(n=2),":[374,376],"FL":[375],"MZL":[377],"(n=1).":[378],"Nine":[379],"completed":[381],"two":[382],"more":[384],"therapy":[387,408],"(median":[388],"3,":[389],"range":[390],"1\u20136)":[391],"280":[393,419,477,523],"(n=6)":[397],"(n=3).":[403],"Two":[404],"who":[406,450,482,569],"discontinued":[407,483],"completing":[411,457],"progressive":[415],"(PD)":[417],"ibrutinib,":[425],"respectively,":[426],"replaced.":[428],"receive":[433],"protocol":[434,567],"treatment.":[435],"The":[436],"5":[437],"off":[439],"replaced":[452],"PD":[454,465],"4,":[470],"patient":[473,550],"receiving":[476,566],"due":[484],"lasting":[489],">":[490],"14":[491],"4.":[495],"No":[496],"DLTs":[497],"have":[498,570],"been":[499],"observed.":[500],"Grade":[501],"3\u20134":[502],"events":[503],"lymphopenia":[505],"(64%),":[506],"(27%),":[508],"thrombocytopenia":[509],"(18%),":[510],"pancreatitis":[511],"(9%),":[512,514,516],"vomiting":[513],"shingles":[515],"rash":[518],"(9%).":[519],"Dose":[520],"reductions":[521,543],"140":[527],"thrombocytopenia,":[537],"pancreatitis,":[538],"rash.":[540],"Bendamustine":[541],"60":[545],"mg/m2were":[546],"thrombocytopenia.":[554],"38%":[557],"8":[559],"evaluable":[560],"patients,":[561],"currently":[565],"treatment":[568,656],"yet":[572],"undergone":[573],"restaging":[574],"scans.":[575],"Responses":[576],"complete":[579],"partial":[583],"MCL.":[590,613],"Conclusions:":[591],"Combined":[592],"appears":[596],"well":[597],"without":[599],"unexpected":[600],"activity":[605],"Three":[614],"additional":[615],"will":[617],"be":[618],"accrued":[619],"level":[625],"expansion":[627],"cohorts":[628],"examining":[629],"this":[630],"specifically":[632],"are":[640],"planned.":[641],"Disclosures:":[642],"Blum:":[643],"Pharmacyclics:":[644],"Research":[645,660,663,666],"Funding.":[646,661,664,667],"Off":[647],"Label":[648],"Use:":[649],"approved":[653],"Jaglowski:Pharmacyclics:":[659],"Maddocks:Pharmacyclics:":[662],"Byrd:Pharmacyclics:":[665]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-03T00:00:00"}